Seeking Alpha

  OncoMed Pharmaceuticals, Inc - NASDAQ

10/26/2014, 1:09 AM ET
  • Ziggle | Send Message 4 Dec 2013

    Short $OMED I feel like the reaction to the news was too intense and expect a pullback. 800 million market cap is an overvaluation.
      OMED vs. ETF Alternatives
      Company Description
      OncoMed Pharmaceuticals Inc is a clinical development-stage biotechnology company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States